Mgo One Seven LLC Editas Medicine, Inc. Transaction History

Mgo One Seven LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$19.43 - $26.41 $34,974 - $47,538	-1,800 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$18.19 - $31.79 $32,742 - $57,222	1,800 New	1,800 $40,000
Q3 2018 Oct 09, 2018	SELL	$27.65 - $38.39 $49,770 - $69,102	-1,800 Closed	0 $0
Q4 2017 Feb 16, 2018	BUY	$21.89 - $31.34 $39,402 - $56,412	1,800	1,800 $55,000

245

56.4M

399K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $190M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.